MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • MDS Virtual Congress 2021

    The Role of the PD Diary Trainer/Reviewer in Parkinson’s Disease Clinical Trials

    C. Mañeru, S. Meyer (Barcelona, Spain)

    Objective: To examine the experience profile of PD Diary raters in clinical trials Background: The Parkinson’s Disease (PD) Home Diary (Hauser, 2000)1 is a widely…
  • MDS Virtual Congress 2021

    Does MDS-UPDRS provide greater sensitivity to mild disease than UPDRS for assessing motor severity in early Parkinson’s disease?

    D. Hall, M. Tosin, C. Patterson, G. Stebbins (Chicago, USA)

    Objective: To test whether The Movement Disorder Society revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III (Motor Examination) items provide increased sensitivity…
  • MDS Virtual Congress 2021

    The Hauser Diary knowledge test as a tool to improve Rater Training Programs in Parkinson’s disease clinical trials

    C. Mañeru, S. Meyer (Barcelona, Spain)

    Objective: To identify the areas with specific training needs for Rater Training Programs (RTP) on the Hauser Diary in Parkinson’s disease (PD) clinical trials Background:…
  • MDS Virtual Congress 2021

    Validation of the Thai version of the MDS-UPDRS

    P. Jagota, P. Srivanitchapoom, S. Petchrutchatachart, S. Singmaneesakulchai, A. Pisarnpong, P. Lolekha, S. Setthawatcharawanich, P. Chairangsaris, N. Limotai, P. Mekawichai, P. Panyakaew, O. Phokaewvarangkul, J. Sringean, N. Lapelle, P. Martinez-Martin, S. Luo, G. Stebbins, C. Goetz, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To validate the Thai translation of the MDS-sponsored revision of the UPDRS (MDS-UPDRS). Background: The MDS-UPDRS was published in 2008 to assess different domains…
  • MDS Virtual Congress 2021

    Secondary endpoints of a randomized, placebo-Controlled Pilot Study to evaluate the safety of lyophilized PRIM-DJ2727 in Parkinson’s disease

    J. Suescun, M. Schiess, Z. Jiang, V. Thyne, T. Iqbal, N. Utay, M. Newmark, A. Dupont, A. Alexander, H. Dupont (Houston, USA)

    Objective: To evaluate the impact of fecal microbiome transplant (FMT) on disease progression as a secondary outcome of a safety study using PRIM-DJ2727 in Parkinson's…
  • MDS Virtual Congress 2021

    The influence of culture on the relationship between subjective and objective assessments of dyskinesia severity.

    V. Kaasinen, CG. Goetz, P. Martinez-Martin, S. Luo, GT. Stebbins (Turku, Finland)

    Objective: To explore the relationship and rate of agreement between patient and clinician evaluation of dyskinesia severity and impact on function across multiple cultures. Background:…
  • MDS Virtual Congress 2021

    Novel approach to MDS-UPDRS monitoring in clinical trials: Longitudinal Item Response Theory Models

    S. Luo, H. Zou, C. Goetz, D. Choi, D. Oakes, T. Simuni, G. Stebbins (Durham, USA)

    Objective: Using the unique advantages of Item Response Theory (IRT), we developed unidimensional and multidimensional models to investigate non-tremor and tremor MDS-UPDRS Part 3 changes…
  • MDS Virtual Congress 2021

    Reliability and Validity of the Greek Translation of the Scale for Assessment and Rating Ataxia in Ataxic Children

    A. Lepoura, S. Lampropoulou, T. Schmitz-Hübsch, T. Panagopoulos, M. Papadopoulou, M. Pyrgeli, V. Papaevangelou, V. Sakellari (Egaleo, Greece)

    Objective: Translation and Cross-cultural adaptation of the Scale for Assessment and Rating Ataxia (SARA) in Greek ataxic pediatric population. Background: Ataxia in the pediatric population…
  • MDS Virtual Congress 2021

    Effects of levodopa on cognitive functions in Parkinson’s disease

    S. Ismailova, S. Prokopenko (Krasnoyarsk, Russian Federation)

    Objective: To assess the dynamics of cognitive functions (CF) under the influence of levodopa in PD patients Background: Our research is devoted to an urgent problem-the…
  • MDS Virtual Congress 2021

    MDS Translation Program for MDS-UPDRS, UDysRS, and MDS-NMS

    S. Luo, N. Lapelle, P. Martin, S. Ali, C. Goetz, G. Stebbins (Durham, USA)

    Objective: To summarize the status of the ongoing MDS-sponsored translation programs for non-English versions of the MDS-UPDRS, UDysRS, and MDS-NMS. Background: The MDS-UPDRS, UDysRS, and…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley